Back
Ryman Hospitality Properties Vs. Denali Therapeutics Industry Stock Comparison
Buy
62
RHP
Ryman Hospitality Properties
Last Price:
103.97
Seasonality Move:
5.72%
Buy
56
DNLI
Denali Therapeutics
Last Price:
30.74
Seasonality Move:
17.79%
Buy
62
Ryman Hospitality Properties (RHP)
is a Buy
Is Ryman Hospitality Properties a Buy, Sell or Hold?
- The current Ryman Hospitality Properties [RHP] share price is $102.93. The Score for RHP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- RHP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.68. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RHP Stock Price Chart
What is Ryman Hospitality Properties's stock price today?
-
The Ryman Hospitality Properties share price today is $102.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RHP is experiencing buying pressure, which is a positive indicator for future bullish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.
RHP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 57 | Buy |
| Chaikin Money Flow: | 301165 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.84 - 102.98) | Buy |
| Bollinger Bands (100): | (99.03 - 104.73) | Buy |
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.67 | Buy |
| Relative Strength Index (14 RSI): | 77.92 | Buy |
| Chaikin Money Flow: | 34344 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.24 - 27.72) | Buy |
| Bollinger Bands (100): | (18.96 - 25.08) | Buy |
RHP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100.59 | Buy |
| 20-day SMA: | 101.54 | Buy |
| 50-day SMA: | 101.09 | Buy |
| 200-day SMA: | 107.16 | Sell |
| 8-day EMA: | 101.24 | Buy |
| 20-day EMA: | 101.11 | Buy |
| 50-day EMA: | 101.29 | Buy |
| 200-day EMA: | 102.49 | Buy |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28 | Buy |
| 20-day SMA: | 26.04 | Buy |
| 50-day SMA: | 24.18 | Buy |
| 200-day SMA: | 20.53 | Buy |
| 8-day EMA: | 28.54 | Buy |
| 20-day EMA: | 26.57 | Buy |
| 50-day EMA: | 24.56 | Buy |
| 200-day EMA: | 22.12 | Buy |
Ryman Hospitality Properties Earnings Growth & RHP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.34 per share, an increase this year of $0.46 per share, and an increase next year of $0.90 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Ryman Hospitality Properties Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Denali Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||